News
AZTA
34.02
-0.53%
-0.18
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Barchart · 23h ago
Weekly Report: what happened at AZTA last week (0914-0918)?
Weekly Report · 5d ago
Azenta formalizes interim CEO pay and retention grants
TipRanks · 09/17 20:17
How Earnings Beat Will Impact Azenta Stock Investors
Simply Wall St · 09/16 16:19
Azenta Price Target Maintained With a $37.00/Share by Needham
Dow Jones · 09/14 14:11
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Azenta (AZTA)
TipRanks · 09/14 14:10
Needham Reiterates Buy on Azenta, Maintains $37 Price Target
Benzinga · 09/14 14:01
Weekly Report: what happened at AZTA last week (0907-0911)?
Weekly Report · 09/14 10:25
Weekly Report: what happened at AZTA last week (0831-0904)?
Weekly Report · 09/07 10:18
Is Azenta (AZTA) Undervalued Following Its CEO Change?
Simply Wall St · 09/05 22:19
Azenta completes B Medical divestiture as Thelema repays vendor loan
Seeking Alpha · 09/04 14:43
Azenta Completes B Medical Divestiture With Loan Repayment
TipRanks · 09/04 13:00
Press Release: Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
Dow Jones · 09/04 12:00
3 Healthcare Stocks We Keep Off Our Radar
Barchart · 09/01 06:42
Weekly Report: what happened at AZTA last week (0824-0828)?
Weekly Report · 08/31 10:26
How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change
Simply Wall St · 08/26 15:32
Stocks making big moves yesterday: Funko, Hims & Hers Health, Azenta, Strategy, and RUM Group
Barchart · 08/25 09:06
Azenta (AZTA) Could Be 35% Overvalued As CEO Change Tests Execution
Simply Wall St · 08/24 18:23
Monday Sector Laggards: Semiconductors, Oil & Gas Refining & Marketing Stocks
NASDAQ · 08/24 17:31
Azenta Shares Fall on $3M Charge, CEO Exit
Dow Jones · 08/24 17:15
More
Webull provides a variety of real-time AZTA stock news. You can receive the latest news about Azenta Inc through multiple platforms. This information may help you make smarter investment decisions.
About AZTA
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.